P
CATX
Perspective Therapeutics Inc
4.370
-0.010-0.23%Pre Market: 4.527 +0.157 +3.60%07:49 04/08 EDT
OPEN/PREV CLOSE4.340/4.380
TODAY RANGE4.200-4.420
VOL431
MARKET CAP497.89M
52 WEEK RANGE1.600-6.16
AVG VOL (3M)3.53M
% TURNOVER0.45%
TURNOVER0
P/E (TTM)-3.1279
% RANGE5.02%
EPS(TTM)-1.3971
P/E(FORWARD)-3.9130
P/B1.569
BVPS2.785
DIVIDEND--
P/S367.23
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP439.09M
SHARES OUTSTANDING113.93M
NEXT EARNINGS04/27-05/12
FREE FLOAT100.48M
LOT SIZE1
EX-DATE06/17/2024
News
Press Releases
Financial Reports
Profile
Dow Jones·03/23 11:00
Perspective Therapeutics Is Maintained at Buy by HC Wainwright & Co.
TipRanks·03/23 10:10
Perspective Therapeutics price target raised to $13 from $12 at H.C. Wainwright
TipRanks·03/19 12:28
Perspective Therapeutics price target raised to $8 from $7 at UBS
Dow Jones·03/18 17:00
Perspective Therapeutics Is Maintained at Buy by B. Riley Securities
Dow Jones·03/18 13:27
Perspective Therapeutics Is Maintained at Buy by UBS
Benzinga·03/18 13:17
UBS Maintains Buy on Perspective Therapeutics, Raises Price Target to $8
TipRanks·03/18 12:51
Perspective Therapeutics price target raised to $13 from $11 at B. Riley
Dow Jones·03/18 12:49
Perspective Therapeutics Price Target Maintained With a $11.00/Share by Wedbush
Same Industry
Name/Symbol
Change%
Price